title: Soluble receptor of advanced glycation end products (sRAGE) indicates response to chemotherapy in pancreatic cancer patients.
authors.affiliation: University Hospital Munich, Institute of Clinical Chemistry, University Hospital Munich, Munich, Germany.
authors.forename: Christin
authors.initials: C
authors.lastname: Wittwer
authors.forename: Stefan
authors.initials: S
authors.lastname: Boeck
authors.forename: Volker
authors.initials: V
authors.lastname: Heinemann
authors.forename: Michael
authors.initials: M
authors.lastname: Haas
authors.forename: Petra
authors.initials: P
authors.lastname: Stieber
authors.forename: Dorothea
authors.initials: D
authors.lastname: Nagel
authors.forename: Stefan
authors.initials: S
authors.lastname: Holdenrieder
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000097:blood / Q000627:therapeutic use*; D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000097:blood*; D000069287:Capecitabine; D002470:Cell Survival / Q000187:drug effects; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D017127:Glycation End Products, Advanced / Q000097:blood*; D024243:HMGB1 Protein / Q000097:blood*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000188:drug therapy*; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D014408:Biomarkers, Tumor; D017127:Glycation End Products, Advanced; D024243:HMGB1 Protein; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil; D000093542:Gemcitabine